Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

An older woman had false beliefs after taking a depression medication, which stopped when she stopped the medication.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

The conclusion is that self-concept, shame, and emotion regulation are key factors in hoarding disorder, body dysmorphic disorder, and trichotillomania, and should be targeted in treatment and research.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Caffeine improves hair growth, thickness, and reduces shedding.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Certain gene variations are linked to better memory in healthy Chinese women.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Eating disorders like anorexia and bulimia cause skin problems, and dermatologists can help detect these disorders early for better treatment outcomes.

Post-COVID syndrome causes long-lasting symptoms like fatigue, breathing issues, and anxiety.

Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.